Kim Doohwa, Im Myungsoo, Ryang Soree, Kim Mijin, Jeon Yun Kyung, Kim Sang Soo, Kim Bo Hyun
Department of Internal Medicine, Pusan National University School of Medicine, Yangsan, Korea.
Biomedical Research Institute, Pusan National University Hospital, Busan, Korea.
Endocrinol Metab (Seoul). 2024 Dec;39(6):856-863. doi: 10.3803/EnM.2024.2006. Epub 2024 Nov 15.
The Controlling Nutritional Status (CONUT) score is an immunonutritional test tool based on serum albumin, total cholesterol, and lymphocyte counts. It has been studied as a simple prognostic predictor for various carcinomas. This study aimed to investigate the association between preoperative CONUT scores and the clinicopathological characteristics in papillary thyroid carcinoma (PTC) patients.
This study included 2,403 PTC patients who underwent total thyroidectomy between 2012 and 2016 at a single tertiary medical center. The CONUT scores were calculated based on preoperative blood tests. The clinicopathological characteristics were retrospectively reviewed. The patients were categorized by the CONUT score (relatively low, 0-2; relatively high, 3-5).
Among the 2,997 PTC patients who underwent total thyroidectomy at Pusan National University Hospital between 2012 and 2016, those without preoperative blood test were excluded (n=149). Finally 2,403 patients were analyzed after excluding 439 patients taking lipid-lowering drugs and six patients without available T stage data after surgery. Based on the CONUT score, the relatively high score group had a lower body mass index (23.7±3.3 kg/m2 vs. 21.9±2.9 kg/m2, P<0.001), more advanced T stage (T stage 3/4, 5.9% vs. 11.4%, P=0.045), and higher extrathyroidal extension (2.1% vs. 7.6%, P=0.005).
Patients included in this large, single-center study all had a preoperative CONUT score of 0-5, but this study demonstrated that higher preoperative CONUT scores were significantly associated with advanced T stage and extrathyroidal extension. The CONUT score, which can be easily used in clinical practice, is thought to be helpful in predicting the aggressiveness of PTC.
控制营养状况(CONUT)评分是一种基于血清白蛋白、总胆固醇和淋巴细胞计数的免疫营养检测工具。它已被作为各种癌症的一种简单预后预测指标进行研究。本研究旨在探讨甲状腺乳头状癌(PTC)患者术前CONUT评分与临床病理特征之间的关联。
本研究纳入了2012年至2016年在一家三级医疗中心接受全甲状腺切除术的2403例PTC患者。根据术前血液检查计算CONUT评分。对临床病理特征进行回顾性分析。患者按CONUT评分分类(相对较低,0 - 2分;相对较高,3 - 5分)。
在2012年至2016年期间在釜山国立大学医院接受全甲状腺切除术的2997例PTC患者中,排除未进行术前血液检查的患者(n = 149)。最终,在排除439例服用降脂药物的患者和6例术后无可用T分期数据的患者后,对2403例患者进行了分析。基于CONUT评分,较高评分组的体重指数较低(23.7±3.3kg/m²对21.9±2.9kg/m²,P < 0.001),T分期更晚(T3/4期,5.9%对11.4%,P = 0.045),甲状腺外侵犯更高(2.1%对7.6%,P = 0.005)。
这项大型单中心研究纳入的患者术前CONUT评分均为0 - 5分,但本研究表明,术前较高的CONUT评分与更晚的T分期和甲状腺外侵犯显著相关。CONUT评分在临床实践中易于使用,被认为有助于预测PTC的侵袭性。